This month’s KELOLAND Living Book Club selection examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the ...

The Sackler dynasty, owners of Purdue Pharma and makers ... As part of the settlement, the billionaire family behind Purdue Pharma has agreed to pay up to $6.5 billion and give up ownership ...

This feature was first published in May 2019 and remains unedited. When the Duchess of Cambridge opened the new Exhibition Road Quarter at the Victoria and Albert Museum on a gorgeous June day two ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...

Purdue Pharma and its owners, the Sackler family, reached a settlement of up to $7.4 billion for its role in the opioid crisis, less than a year after the Supreme Court tossed out a proposed $6 ...

The Sackler family and its company, Purdue Pharma, reached a settlement with a coalition of 15 states in relation to their involvement in the United States opioid crisis. If approved, the January ...

Jan. 23 (UPI) --The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states. New York Attorney ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

Purdue Pharma and the Sackler family will pay $7.4 billion for their role in the opioid epidemic. Delaware will receive over $27 million from the settlement. The settlement comes just shy of a ...

Purdue Pharma and its owners, the Sackler family, reached a settlement of up to $7.4 billion for its role in the opioid crisis, less than a year after the Supreme Court tossed out a proposed $6 ...